Skip to main content

Day: December 6, 2021

Lexington Realty Trust Comments on Land & Buildings’ Nominations

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“LXP”), a real estate investment trust focused on single-tenant industrial real estate investments, today issued the following statement in response to Land & Buildings Investment Management, LLC’s (“Land & Buildings”) announcement of its nomination of two trustee candidates to stand for election to LXP’s Board of Trustees (the “Board”) at LXP’s 2022 annual meeting of shareholders (the “2022 Annual Meeting”): LXP maintains an ongoing dialogue with the investment community and values constructive input that may advance our goal of enhancing shareholder value. To that end, LXP has been transparent in its discussions with representatives of Land & Buildings as detailed in LXP’s letter to shareholders dated October 6, 2021 and has met with...

Continue reading

A Blinded Evaluation of the Connection Study – Sustained Feeding Tolerance (SFT) Correlates to Clinical Outcomes

A blinded evaluation of IBT’s Connection Study will be presented by Professor Josef Neu, University of Florida, at the 2021 Hot Topics in Neonatology® on December 6, 2021. The evaluation reveals that even a modest reduction in time to Sustained Feeding Tolerance (SFT) correlates positively to several clinically meaningful outcomes including Sepsis and Bronchopulmonary Dysplasia, a chronic lung disease that affects premature newborns. Given that IBT’s product IBP-9414 is first in class, there were no validated endpoints established for SFT, the Connection Study’s second primary endpoint. Prior to initiating the study, IBT and the FDA therefore agreed on an appropriate validation procedure, the result of which has now been presented by Professor Josef Neu. IBT’s Clinical Phase III study of the drug candidate IBP-9414 for the prevention of...

Continue reading

Adagene Presents Clinical Data Demonstrating Strong Safety and Early Signals of Efficacy in Cold Tumors Including Pancreatic and Ovarian Cancers for Anti-CTLA-4 Monoclonal Antibody, ADG116, at ESMO-IO 2021

Additional highlights include pharmacodynamic biomarker analyses from ongoing trial of anti-CD137 antibody, ADG106, in combination with anti-PD-1 toripalimab SAN DIEGO and SUZHOU, China, Dec. 06, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced clinical data on its anti-CTLA-4 monoclonal antibody, ADG116, and anti-CD137 agonist, ADG106, in two poster presentations at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021, to be held virtually and in Geneva, Switzerland from December 8 to 11, 2021. Both posters are available in the Publications section of the company’s website at www.adagene.com. In the first presentation...

Continue reading

Great Southern Bancorp, Inc. Announces Fourth Quarter 2021 Preliminary Earnings Release Date and Conference Call

SPRINGFIELD, Mo., Dec. 06, 2021 (GLOBE NEWSWIRE) — Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, expects to report fourth quarter 2021 preliminary earnings after the market closes on Monday, January 24, 2022, and host a conference call on Tuesday, January 25, 2022, at 2:00 p.m. Central Time (3:00 p.m. Eastern Time). Individuals interested in listening to the conference call may dial 1.833.832.5121 and enter the passcode 3989279. The call will be available live or in a recorded version at the Company’s Investor Relations website, https://investors.greatsouthernbank.com. The Company will notify the public that fourth quarter 2021 results have been issued through a news release and will post the results to the Company’s Investor Relations website. The earnings release will also be available...

Continue reading

CUMULUS MEDIA and Signal Hill Insights’ Podcast Download – Fall 2021 Report Reveals Latest Podcast Trends

Podcast Advertising Reaches Young Cord Cutters Who Prefer Advertising-Free Video Streaming Spotify Is Now the Leading Podcast Listening Destination Women Represent the Majority of New Podcast Listeners There Are Now Six Social Audio Brands with Similar Listener Awareness and Usage NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — CUMULUS MEDIA (NASDAQ: CMLS), in partnership with Signal Hill Insights, today released Cumulus Media and Signal Hill Insights’ Podcast Download – Fall 2021 Report, a comprehensive evaluation incorporating several new studies that examine podcast audience and advertiser trends over the past five years. The seventh edition of the study that examines weekly podcast listeners is part of Cumulus Media’s commitment to share insights and research findings with the podcast community. Topics covered in the Podcast Download...

Continue reading

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH). Oppenheimer’s Imagine AI + Healthcare Investor SummitDate:        Tuesday, December 7thTime:        11:00 a.m. to 11:20 a.m. ETRegistration Link About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com. Contact:Media Inquiries:Jessica Burns, iCAD +1-201-423-4492jburns@icadmed.com Investor...

Continue reading

Winnebago Industries’ First Quarter Fiscal 2022 Financial Results Announcement to be Made on December 17, 2021

EDEN PRAIRIE, Minn., Dec. 06, 2021 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, plans to issue its earnings release for its first quarter Fiscal 2022 before the market opens on December 17, 2021. The Company will also host a conference call to discuss the financial results for the quarter on Friday, December 17, 2021, at 9 a.m. CST. All interested parties are invited to listen live via the Company’s website, http://investor.wgo.net. The event will be archived and available for replay for the next 90 days. To access the replay, click on https://winnebago.gcs-web.com/event-calendar. About Winnebago Industries Winnebago Industries, Inc. is a leading North American manufacturer of outdoor lifestyle products under the Winnebago, Grand Design, Chris-Craft, Newmar and...

Continue reading

BNP PARIBAS Group: end of 900 million euros share buyback program

Paris, 06 December 2021 BNP Paribas announces the end of its 900 million euros share buyback program The BNP Paribas share buyback program, which started on 01 November 2021, was fully completed on 06 December 2021. Between 01 November 2021 and 06 December 2021, 15 466 915 BNP Paribas’ shares were purchased for an overall purchase price of EUR 900 million, the maximum amount of the program. Accordingly, the irrevocable instruction given to an investment service provider acting independently for the execution of the share buyback program announced on 29 October 2021 ended on the 06 December 2021.In accordance with the announcement made on 29 October 2021, shares acquired in the context of this share buyback program will be cancelled. The description and the weekly information on the progress of the program to purchase shares executed since...

Continue reading

Magnetic North Acquisition Corp. Announces First Closing of Non-Brokered Private Placement of Up to $2 Million

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws** CALGARY, Alberta and TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”) is pleased to announce a first closing of the Company’s non-brokered private placement (the “Financing”) of Series A Preferred Shares for gross proceeds of up to $2,000,006.50 CAD. On December 3, 2021 the Company completed the issuance of 105,264 units of Series A Preferred Shares at a price of $9.50 per share for gross proceeds of $1,000,008.00 CAD. The Company paid no finder’s fees relating to the completion of the first closing. The...

Continue reading

Icelandair Group hf.: Traffic Data November 2021

The total number of Icelandair‘s passengers and capacity increased significantly in November 2021 compared to November 2020. The total capacity in November reached 63% of November 2019 capacity levels. Year-to-date, Icelandair passengers have reached 1.3 million in 2021. The total number of passengers on international and domestic flights was around 170,000 compared to around 13,000 in November 2020 and 283,000 in November 2019. Thereof, the total number of passengers on international flights was around 151,000. The number of passengers to Iceland was around 80,000 and from Iceland around 33,000. Via passengers were around 38,000. On-time performance was 75%. The load factor on international flights was 71% compared to 32% in November 2020 and 79% in November 2019. The load factor on flights to and from North America increased significantly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.